These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 37839675

  • 21. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K, Denizon N, Besançon A, Farhi J, Lemaire P, Sandrini J, Truong C, Ghnaya H, Baugier de Materre A.
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
    [Abstract] [Full Text] [Related]

  • 22. Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
    Pollyea DA, Altman JK, Assi R, Bixby D, Fathi AT, Foran JM, Gojo I, Hall AC, Jonas BA, Kishtagari A, Lancet J, Maness L, Mangan J, Mannis G, Marcucci G, Mims A, Moriarty K, Mustafa Ali M, Neff J, Nejati R, Olin R, Percival ME, Perl A, Przespolewski A, Rao D, Ravandi F, Shallis R, Shami PJ, Stein E, Stone RM, Sweet K, Thota S, Uy G, Vachhani P, Cassara CJ, Freedman-Cass DA, Stehman K.
    J Natl Compr Canc Netw; 2023 May; 21(5):503-513. PubMed ID: 37156478
    [Abstract] [Full Text] [Related]

  • 23. Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow : Summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016.
    Tzankov A, Hebeda K, Kremer M, Leguit R, Orazi A, van der Walt J, Gianelli U.
    Ann Hematol; 2017 May; 96(5):765-777. PubMed ID: 28191591
    [Abstract] [Full Text] [Related]

  • 24. Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).
    Beird HC, Khan M, Wang F, Alfayez M, Cai T, Zhao L, Khoury J, Futreal PA, Konopleva M, Pemmaraju N.
    Blood Cancer J; 2019 Dec 06; 9(12):99. PubMed ID: 31811114
    [Abstract] [Full Text] [Related]

  • 25. Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia.
    Loghavi S, DiNardo CD, Furudate K, Takahashi K, Tanaka T, Short NJ, Kadia T, Konopleva M, Kanagal-Shamanna R, Farnoud NR, Pierce S, Khoury JD, Jorgensen JL, Patel KP, Daver N, Yilmaz M, Medeiros LJ, Kantarjian H, Ravandi F, Wang SA.
    Br J Haematol; 2021 Mar 06; 192(6):1054-1063. PubMed ID: 33618432
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Johnson RC, Kim J, Natkunam Y, Sundram U, Freud AG, Gammon B, Cascio MJ.
    Am J Surg Pathol; 2016 Apr 06; 40(4):502-9. PubMed ID: 26796502
    [Abstract] [Full Text] [Related]

  • 30. Clinicopathological analysis of 46 cases with CD4+ and/or CD56+ immature haematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and related neoplasms.
    Suzuki Y, Kato S, Kohno K, Satou A, Eladl AE, Asano N, Kono M, Kato Y, Taniwaki M, Akiyama M, Nakamura S.
    Histopathology; 2017 Dec 06; 71(6):972-984. PubMed ID: 28795410
    [Abstract] [Full Text] [Related]

  • 31. Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome.
    Yasuda H, Takaku T, Tomomatsu J, Hosone M, Tanaka H, Komatsu N.
    Intern Med; 2014 Dec 06; 53(23):2717-20. PubMed ID: 25447656
    [Abstract] [Full Text] [Related]

  • 32. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis.
    Loberg MA, Bell RK, Goodwin LO, Eudy E, Miles LA, SanMiguel JM, Young K, Bergstrom DE, Levine RL, Schneider RK, Trowbridge JJ.
    Leukemia; 2019 Jul 06; 33(7):1635-1649. PubMed ID: 30692594
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Neoplasms derived from plasmacytoid dendritic cells.
    Facchetti F, Cigognetti M, Fisogni S, Rossi G, Lonardi S, Vermi W.
    Mod Pathol; 2016 Feb 06; 29(2):98-111. PubMed ID: 26743477
    [Abstract] [Full Text] [Related]

  • 36. Plasmacytoid dendritic cells in the setting of myeloid neoplasms: Diagnostic guide to challenging pathologic presentations.
    El Hussein S, Wang W.
    Br J Haematol; 2023 Mar 06; 200(5):545-555. PubMed ID: 36606610
    [Abstract] [Full Text] [Related]

  • 37. Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML.
    Guardia RD, González-Silva L, López-Millán B, Rodríguez-Sevilla JJ, Baroni ML, Bueno C, Anguita E, Vives S, Palomo L, Lapillonne H, Varela I, Menendez P.
    Genes (Basel); 2020 Jan 09; 11(1):. PubMed ID: 31936647
    [Abstract] [Full Text] [Related]

  • 38. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review.
    Ding Y, Yang J, Lindsey K.
    Diagn Cytopathol; 2021 Feb 09; 49(2):E80-E83. PubMed ID: 32852895
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.